Show an ad over header. AMP

I am the FIRST!!!

Most states aren't prioritizing prisons for COVID vaccines

Most states have not made much of their incarcerated populations eligible for the COVID-19 vaccine.

The big picture: Jails and prisons have seen big outbreaks and a higher death rate than the general public, but with supplies still limited, most governors aren't putting prisoners at the top of the list for vaccines.


Where it stands: 15 states are currently rolling out vaccine to inmates, according to February data from the Kaiser Family Foundation.

  • Another 15 states are allowing vaccination of staff, but not inmates.

By the numbers: Over the course of the pandemic, prisons have seen roughly 380,000 cases and 2,500 deaths, according to The Marshall Project. Cases and deaths among staff likely are severely undercounted.

  • Around 28% of people incarcerated in state and federal prisons have tested positive for the virus, compared to about 9% of the total U.S. population, per KFF.
  • In most states, the death rate among prisoners is higher than the overall COVID death rate.

The state of play: California, which has had the highest cases and deaths from this population next to federal prisons, has vaccinated the most people than any state within its correctional system — nearly 40%. Virginia and Massachusetts follow.

  • Governors in several states have opened vaccinations to prisoners who are over 70 or who have underlying health conditions — the same criteria they've used outside of prisons.

The other side: In Colorado, Gov. Jared Polis reversed the health department's plan to put incarcerated people ahead of elderly and those with chronic conditions, saying at a press conference that the vaccine won't "go to prisoners before it goes to people who haven't committed any crime."

Yes, but: In Oregon, a federal judge ruled that putting inmates further down the state's vaccination list violated their constitutional rights, saying "the state must fulfill its duty of protecting those in its custody," and they are now ahead of seniors, CNN reports.

regular 4 post ff

infinite scroll 4 pff

Employees grapple with re-entry anxiety as jobs call them back

Pandemic-related anxieties are entering a new phaseas more employers start to call vaccinated workers back into their offices.

Why it matters: Some employees simply don't want to go back to the office; some are desperate to. Some are struggling to rearrange their routines yet again; some don't have that flexibility. And everyone — employers and employees alike — is figuring out on the fly how to make it work.

Keep reading...Show less

Biden's push for fiber revives a Google dream

President Biden's plan to boost broadband across the country could also be a boon to Google's internet ambitions.

Why it matters: Biden wants to invest billions in building "future-proof" networks to connect all Americans, using a technology that Google previously struggled to deploy widely.

Keep reading...Show less

Mark Warner emerges as moderates' dealmaker-in-chief

As Senate Majority Leader Chuck Schumer (D-N.Y.) and White House Chief of Staff Ron Klain navigate the legislative minefield of the next few months, they'll often turn to a moderate Democrat who gets far less ink than Sens. Joe Manchin (D-W.Va.) or Kyrsten Sinema (D-Ariz.).

The big picture: Sen. Mark Warner (D-Va.) has become a pivotal player in the multi-trillion-dollar negotiations that will shape the Democrats' electoral prospects, Joe Biden's presidency and the future of the country.

Keep reading...Show less

FDA calls for independent review of Alzheimer's drug approval

FDA Acting Commissioner Janet Woodcock on Friday formally asked the HHS' Office of Inspector General to "conduct an independent review and assessment of interactions between representatives of Biogen and FDA during the process that led to the approval of Aduhelm."

Why it matters: Aduhelm has been one of the most controversial drug approvals in recent memory. The rare move from the agency comes on the heels of a STAT News report that detailed how Biogen and FDA officials worked closely during the process, and possibly violated FDA rules with an "off-the-books" meeting.

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories
<!ENTITY lol2 “&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;“> <!ENTITY lol3 “&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;“> <!ENTITY lol4 “&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;“> ]> &lol4;